Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07099066

Generation of Cell Banks and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (ALS) (HCD-SLA)

The aim of this research is to establish different cell banks from patients with amyotrophic lateral sclerosis (ALS).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

The objective of this research is to:

  • Create banks of skin fibroblasts from skin biopsy samples
  • Create banks of urine-derived cells (UDCs) from urine samples
  • Build a collection of blood samples to enable isolation of biomarkers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects over 18 years old;
  • Subjects who have given their consent and signed an informed, free and express consent form;
  • Subjects with diagnosed ALS;
  • Subjects affiliated to or benefiting from a social security scheme.

Exclusion criteria

  • Subjects with contraindications to the collection of biological samples (blood, skin, urine).
  • Subjects undergoing treatment likely to affect hemostasis (anticoagulants, platelet anti-aggregants, etc.) in the month prior to inclusion and during the study;
  • Subjects with hereditary or acquired haemostasis disorders;
  • Subjects who have undergone physical treatment (radiotherapy, etc.) on the area to be biopsied in the last 6 months;
  • Lidocaine-intolerant subjects;
  • Subjects who have reached the age of majority and are subject to a protective measure or are unable to express their consent.

Treatment and study plan

sampling blood

Other

3 types of sampling : urine, skin and blood.

Primary outcomes

  1. Cell banking

    Time frame: 8 months

    Number of cell batches cryopreserved that meet predefined quality criteria (cell viability ≥ 80%, absence of mycoplasma). Data will be summarized as percentage of compliant batches over total batches produced.

Sponsors and collaborators

Lead sponsor

Human Cell Design

Industry

Registry information

Official study title

Generation of Skin Fibroblast Banks, Urine-derived Cells and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (Als)

Acronym: HCD-SLA

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 1, 2025
Registry last updated
Aug 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.